CPT code 83721 represents a direct measurement of low density lipoprotein (LDL) cholesterol performed by a laboratory analyst on a patient specimen. Direct LDL measurement is clinically important for assessing cardiovascular risk and guiding lipid-lowering therapies, especially in patients with hypertriglyceridemia or when calculated LDL may be unreliable. Nationally, accurate LDL measurement supports preventive cardiology and chronic disease management programs.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find clinical context for when direct LDL testing is used, common sites of service, and the role of this test within laboratory and cardiometabolic care pathways. The publication provides benchmarks and policy-relevant information about coverage patterns and coding practice where available.

The analysis also summarizes typical service settings, conveys common billing modifiers when relevant, and highlights gaps where input data is not available. This resource is intended for billing professionals, laboratory managers, and policy analysts who need a concise reference on the clinical meaning, payer landscape, and administrative considerations associated with CPT code 83721.